329 related articles for article (PubMed ID: 30825335)
1. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
[TBL] [Abstract][Full Text] [Related]
2. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
[TBL] [Abstract][Full Text] [Related]
3. Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
Cappello F; Angerilli V; Dal Santo L; Munari G; Sabbadin M; Lo Mele M; Pennelli G; Luchini C; Parente P; Lazzi S; Fassan M
Pathol Res Pract; 2022 Dec; 240():154214. PubMed ID: 36395596
[TBL] [Abstract][Full Text] [Related]
4. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
[TBL] [Abstract][Full Text] [Related]
5. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
Caruso M; Moore J; Goodall GJ; Thomas M; Phillis S; Tyskin A; Cheetham G; Lerda N; Takahashi H; Ruszkiewicz A
Virchows Arch; 2009 Mar; 454(3):291-302. PubMed ID: 19172291
[TBL] [Abstract][Full Text] [Related]
6. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic features with associated histological and molecular alterations in serrated polyps with dysplasia: Retrospective analysis of a tertiary case series.
Trecca A; Borghini R; Medicina D; Del Sordo R; Mandelli G; Bella A; Galloro G; Fu KI; Villanacci V
Dig Liver Dis; 2024 Apr; 56(4):687-694. PubMed ID: 37778895
[TBL] [Abstract][Full Text] [Related]
9. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations.
Agaimy A; Stoehr R; Vieth M; Hartmann A
Am J Surg Pathol; 2010 Nov; 34(11):1663-71. PubMed ID: 20962618
[TBL] [Abstract][Full Text] [Related]
10. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
11. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas.
Travaglino A; D'Armiento FP; Cassese G; Campanino MR; Borrelli G; Pignatiello S; Luglio G; Maione F; De Palma GD; D'Armiento M
Histopathology; 2019 Aug; 75(2):160-173. PubMed ID: 30815911
[TBL] [Abstract][Full Text] [Related]
13. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
Kuan SF; Navina S; Cressman KL; Pai RK
Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
[TBL] [Abstract][Full Text] [Related]
15. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
Kim YH; Kakar S; Cun L; Deng G; Kim YS
Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
[TBL] [Abstract][Full Text] [Related]
17. Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia.
Hua X; Newcomb PA; Chubak J; Malen RC; Ziebell R; Kamineni A; Zhu LC; Upton MP; Wurscher MA; Thomas SS; Newman H; Hardikar S; Burnett-Hartman AN
Cancer Causes Control; 2020 Jul; 31(7):631-640. PubMed ID: 32358694
[TBL] [Abstract][Full Text] [Related]
18. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of MLH1 in non-dysplastic crypts is a harbinger of neoplastic progression in sessile serrated adenomas/polyps.
Yozu M; Kem M; Cenaj O; Mino-Kenudson M; Odze RD; Misdraji J
Histopathology; 2019 Sep; 75(3):376-384. PubMed ID: 30974487
[TBL] [Abstract][Full Text] [Related]
20. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
